Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M L Smidt

Showing results (21-30 of 49) with videos related to

Pageof 5
Sort By:
Journal of Cancer|February 6, 2019
Can high school students help to improve breast radiologists in detecting missed breast cancer lesions on full-field digital mammography?T J A van Nijnatten, M L Smidt, B Goorts, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 10, 2021
The percentage of residual DCIS in patients diagnosed with primary invasive breast cancer treated with neoadjuvant systemic therapy: A nationwide retrospective studyR A W Ploumen, K B M I Keymeulen, L F S Kooreman, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
A mutation in human immunodeficiency virus type 1 protease at position 88, located outside the active site, confers resistance to the hydroxyethylurea inhibitor SC-55389AM L Smidt, K E Potts, S P Tucker, et al.
Breast (Edinburgh, Scotland)|September 13, 2013
No increase of local recurrence rate in breast cancer patients treated with skin-sparing mastectomy followed by immediate breast reconstructionD R J van Mierlo, T R Lopez Penha, R J Schipper, et al.
Insights Into Imaging|March 25, 2015
The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic reviewV J L Kuijs, M Moossdorff, R J Schipper, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 22, 2021
Test-Retest Data for the Assessment of Breast MRI Radiomic Feature RepeatabilityR W Y Granzier, A Ibrahim, S Primakov, et al.
Breast Cancer Research and Treatment|February 19, 2017
Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastasesT J A van Nijnatten, J M Simons, M Moossdorff, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 15, 2017
Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility studyThiemo J A van Nijnatten, B Goorts, S Vöö, et al.
Breast Cancer Research and Treatment|January 7, 2014
The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patientsL M van Roozendaal, R J Schipper, K K B T Van de Vijver, et al.
Clinical Radiology|July 19, 2022
Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid <sup>18</sup>F-FDG PET/MRI in clinically node-positive breast cancer patients: a pilot studyC M de Mooij, S Samiei, C Mitea, et al.
Pageof 5

Showing results (21-30 of 49) with videos related to

Sort By:
Pageof 5
Journal of Cancer|February 6, 2019
Can high school students help to improve breast radiologists in detecting missed breast cancer lesions on full-field digital mammography?T J A van Nijnatten, M L Smidt, B Goorts, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|November 10, 2021
The percentage of residual DCIS in patients diagnosed with primary invasive breast cancer treated with neoadjuvant systemic therapy: A nationwide retrospective studyR A W Ploumen, K B M I Keymeulen, L F S Kooreman, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
A mutation in human immunodeficiency virus type 1 protease at position 88, located outside the active site, confers resistance to the hydroxyethylurea inhibitor SC-55389AM L Smidt, K E Potts, S P Tucker, et al.
Breast (Edinburgh, Scotland)|September 13, 2013
No increase of local recurrence rate in breast cancer patients treated with skin-sparing mastectomy followed by immediate breast reconstructionD R J van Mierlo, T R Lopez Penha, R J Schipper, et al.
Insights Into Imaging|March 25, 2015
The role of MRI in axillary lymph node imaging in breast cancer patients: a systematic reviewV J L Kuijs, M Moossdorff, R J Schipper, et al.
Journal of Magnetic Resonance Imaging : JMRI|December 22, 2021
Test-Retest Data for the Assessment of Breast MRI Radiomic Feature RepeatabilityR W Y Granzier, A Ibrahim, S Primakov, et al.
Breast Cancer Research and Treatment|February 19, 2017
Prognosis of residual axillary disease after neoadjuvant chemotherapy in clinically node-positive breast cancer patients: isolated tumor cells and micrometastases carry a better prognosis than macrometastasesT J A van Nijnatten, J M Simons, M Moossdorff, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 15, 2017
Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility studyThiemo J A van Nijnatten, B Goorts, S Vöö, et al.
Breast Cancer Research and Treatment|January 7, 2014
The impact of the pathological lymph node status on adjuvant systemic treatment recommendations in clinically node negative breast cancer patientsL M van Roozendaal, R J Schipper, K K B T Van de Vijver, et al.
Clinical Radiology|July 19, 2022
Axillary lymph node response to neoadjuvant systemic therapy with dedicated axillary hybrid <sup>18</sup>F-FDG PET/MRI in clinically node-positive breast cancer patients: a pilot studyC M de Mooij, S Samiei, C Mitea, et al.
Pageof 5